List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 119 studies with search of: lymphoma [CONDITION] AND "Phase III" [PHASE] | Open Studies
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP
Conditions: Peripheral T Cell Lymphoma, Unspecified;   Angioimmunoblastic Lymphadenopathy;   AIL Type Lymphoma;   Anaplastic Large Cell Lymphoma, ALK Negative;   Extranodal NK/T-Cell Lymphoma
Interventions: Biological: alemtuzumab;   Drug: chemotherapy
2 Recruiting First-Line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.
Conditions: Follicular Lymphoma;   Marginal Zone Lymphoma;   Small Lymphocytic Lymphoma;   Lymphoplasmacytic Lymphoma
Interventions: Drug: Rituximab, Cyclophosphamide, Vincristine, Prednisone;   Drug: Rituximab, Cyclophosphamid, Doxorubicin, Vincristine, Prednisone
3 Recruiting Helicobacter – Lymphoma – Radiation Part I: Eradication, Part II: Radiation
Conditions: Lymphoma;   Lymphoma, Non-Hodgkin
Interventions: Drug: proton pump inhibitor;   Drug: clarithromycin;   Drug: amoxicillin;   Drug: metronidazole;   Procedure: radiation therapy
4 Recruiting Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma
Condition: Lymphoma
Interventions: Procedure: autologous hematopoietic stem cell transplantation;   Procedure: leukapheresis
5 Not yet recruiting Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma
Condition: Lymphoma, Large-Cell, Diffuse
Interventions: Drug: RITUXIMAB + DHAP;   Drug: RITUXIMAB + DVD;   Drug: OFATUMUMAB + DVD;   Drug: OFATUMUMAB + DHAP
6 Recruiting Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas
Conditions: Follicular Lymphomas;   Immunocytomas;   Marginal Zone Lymphomas;   Mantle-Cell Lymphomas;   Non-Hodgkin's Lymphoma
Interventions: Drug: Rituximab;   Drug: Rituximab / observation
7 Recruiting A Study to Evaluate the Efficacy of Lenalidomide as Maintenance Therapy After Completion of First-line Combination Chemotherapy in Patients With Mantle Cell Lymphoma (MCL).
Conditions: Mantle Cell Lymphoma;   Non-Hodgkin's Lymphoma
Interventions: Drug: Lenalidomide;   Other: Placebo
8 Recruiting Fludarabine and Cyclophosphamide With or Without Rituximab in Treating Patients With Previously Untreated Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Genetic: fluorescence in situ hybridization;   Other: immunohistochemistry staining method;   Other: immunologic technique;   Other: laboratory biomarker analysis
9 Recruiting Alemtuzumab and CHOP in T-cell Lymphoma
Condition: Lymphoma, T-Cell, Peripheral
Interventions: Drug: CHOP14 chemotherapy (cyclophosphamide, hydroxydaunorubicin, vincristin, prednison) plus G-CSF, combined with alemtuzumab;   Drug: CHOP14 chemotherapy (see specification under Arm B) plus G-CSF
10 Recruiting Study of Oral LBH589 in Adult Patients With Refractory/Resistant Cutaneous T-Cell Lymphoma
Condition: Cutaneous T-Cell Lymphoma
Intervention: Drug: LBH589
11 Recruiting Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma
Conditions: Diffuse Large B-Cell Lymphoma;   IPI≥2
Interventions: Drug: Rituximab;   Drug: Ciclofosfamide;   Drug: Doxorubicina;   Drug: Vincristina;   Drug: Prednisone;   Drug: Pegfilgrastim;   Drug: Mitoxantrone;   Drug: ARA-C;   Drug: Lenograstim;   Drug: BCNU;   Drug: VP-16;   Procedure: ASCT
12 Recruiting Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy
Condition: Diffuse Large B-cell Lymphoma
Interventions: Drug: RAD001;   Drug: Placebo
13 Recruiting CHOP Versus CEOP-induced Cardiotoxicity in Patients With Aggressive B-cell Lymphoma
Condition: Lymphoma
Interventions: Drug: CEOP regimen;   Drug: CHOP regimen
14 Recruiting This is a Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM.
Conditions: Lymphoma (Non-Hodgkin's Lymphoma);   Hodgkin's Disease or Multiple Myeloma;   Front Line Mobilization, Transplantation
Intervention: Drug: Generic = Plerixafor
15 Recruiting Multicentric Study, Three Randomized Arms (R−CVP vs R−CHOP vs R−FM),for Patients With Stage II−IV Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: R-CVP;   Drug: R-CHOP;   Drug: R-FM
16 Recruiting Mature B-Cell Lymphoma And Leukemia Study III
Condition: Mature B-Cell Lymphoma
Interventions: Drug: COPAD;   Drug: COP, COPD M3, CYM;   Drug: COP, COPADM8, CYVE
17 Recruiting Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: Cyclophosphamide;   Radiation: Radiotherapy;   Drug: Vincristine;   Drug: Prednisolone;   Drug: Rituximab
18 Recruiting Mantel Cell Lymphoma Efficacy of Rituximab Maintenance
Condition: Mantle Cell Lymphoma
Interventions: Drug: Rituximab;   Other: Watch and wait
19 Recruiting Treatment of Aggressive Localized Lymphoma
Condition: Localized Diffuse B Cell Lymphoma
Interventions: Drug: rituximab;   Drug: doxorubicin;   Drug: vincristine;   Drug: prednisone;   Procedure: radiotherapy
20 Recruiting Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL
Condition: Lymphoma, Mantle-Cell
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone;   Drug: Fludarabine;   Drug: Interferon-alpha;   Drug: pegylated formula Interferon-alpha 2b;   Procedure: chemotherapy: R-CHOP;   Procedure: chemotherapy: R-FC;   Procedure: Interferon maintenance;   Procedure: Rituximab maintenance

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services